HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George M Warimwe Selected Research

Rift Valley Fever

10/2021Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations.
11/2019Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components.
1/2019Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats.
4/2016Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle.
2/2016Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.
12/2013Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George M Warimwe Research Topics

Disease

11Malaria
11/2019 - 10/2007
7Infections
01/2021 - 01/2013
6Rift Valley Fever
10/2021 - 12/2013
2COVID-19
12/2021 - 10/2021
2Yellow Fever
01/2021 - 01/2019
1Coma (Comas)
01/2022
1Emerging Communicable Diseases (Emerging Infectious Diseases)
12/2021
1Poliomyelitis (Polio)
01/2021
1Rabies (Hydrophobia)
11/2019
1Viremia
01/2019
1Microcephaly
01/2019
1Parasitemia
01/2019
1Communicable Diseases (Infectious Diseases)
01/2018
1Ebola Hemorrhagic Fever
01/2017
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2016
1Tuberculosis (Tuberculoses)
02/2014

Drug/Important Bio-Agent (IBA)

14VaccinesIBA
12/2021 - 09/2012
6AntibodiesIBA
01/2019 - 12/2009
3AntigensIBA
01/2019 - 10/2007
3Surface Antigens (Surface Antigen)IBA
09/2012 - 12/2009
2Recombinant ProteinsIBA
01/2019 - 10/2007
1ChAdOx1 nCoV-19IBA
10/2021
1Rabies Vaccines (Rabies Vaccine)FDA Link
10/2021
1Viral Envelope ProteinsIBA
11/2020
1Neutralizing AntibodiesIBA
11/2020
1Immunoglobulin M (IgM)IBA
01/2019
1Monoclonal AntibodiesIBA
12/2018
1Middle East respiratory syndrome vaccineIBA
01/2017
1TrehaloseIBA
04/2016
1Sucrose (Saccharose)IBA
04/2016
1SugarsIBA
04/2016
1Adenovirus VaccinesIBA
02/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Plasmodium falciparum erythrocyte membrane protein 1IBA
01/2016
1Immunodominant EpitopesIBA
01/2016
1Blood Group Antigens (Blood Groups)IBA
09/2014
1Angiopoietin-2IBA
03/2014
1Malaria VaccinesIBA
09/2012
1Cysteine (L-Cysteine)FDA Link
12/2009
1Immunoglobulin G (IgG)IBA
10/2007

Therapy/Procedure

2Contraindications
01/2022 - 01/2021
1Therapeutics
02/2014